NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+17.55%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.45B
AUM Growth
+$1.45B
(-19%)
Cap. Flow
-$207M
Cap. Flow
% of AUM
-14.28%
Top 10 Holdings %
Top 10 Hldgs %
62.93%
Holding
58
New
1
Increased
5
Reduced
10
Closed
5
Top Buys
| 1 |
Geron
GERN
|
$10.9M |
| 2 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
$4.83M |
| 3 |
ADXN
Addex Therapeutics
ADXN
|
$900K |
| 4 |
Senti Biosciences
SNTI
|
$287K |
| 5 |
Wheels Up
UP
|
$29K |
Top Sells
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$66.2M |
| 2 |
Cloudflare
NET
|
$38.5M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$35.7M |
| 4 |
Coursera
COUR
|
$34.6M |
| 5 |
EAR
Eargo, Inc. Common Stock
EAR
|
$20.1M |
Sector Composition
| 1 | Healthcare | 67.32% |
| 2 | Technology | 13.44% |
| 3 | Consumer Staples | 10.25% |
| 4 | Industrials | 7.8% |
| 5 | Communication Services | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coursera
COUR
$1.88B
| $148M | 10.25% | 12,867,769 -3,000,000 | -19% | -$34.6M |
|
2
Arcellx
ACLX
$3.85B
| $146M | 10.11% | 4,745,262 | – | – |
|
|
VRNA
3
Verona Pharma
VRNA
$9.16B
| $112M | 7.75% | 5,584,753 | – | – |
|
4
Mirum Pharmaceuticals
MIRM
$3.71B
| $101M | 6.95% | 4,186,243 | – | – |
|
5
IonQ
IONQ
$12.7B
| $89.9M | 6.21% | 14,614,829 | – | – |
|
|
6
Cloudflare
NET
$72.7B
| $77M | 5.32% | 1,249,215 -624,608 | -33% | -$38.5M |
|
7
CRISPR Therapeutics
CRSP
$4.71B
| $71.8M | 4.96% | 1,587,854 | – | – |
|
8
Monte Rosa Therapeutics
GLUE
$296M
| $59.9M | 4.14% | 7,692,298 | – | – |
|
|
BGRY
9
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $52.7M | 3.64% | 38,183,023 | – | – |
|
|
10
Rhythm Pharmaceuticals
RYTM
$6.85B
| $51.9M | 3.59% | 2,909,956 -2,000,000 | -41% | -$35.7M |
|
11
NeueHealth
NEUE
$59.2M
| $48.1M | 3.32% | 218,153,623 | – | – |
|
12
Savara
SVRA
$567M
| $47.1M | 3.25% | 24,137,931 | – | – |
|
|
13
Geron
GERN
$893M
| $46.3M | 3.2% | 21,347,838 +5,029,157 | +31% | +$10.9M |
|
14
Aurinia Pharmaceuticals
AUPH
$1.58B
| $43.5M | 3.01% | 3,969,834 | – | – |
|
|
DM
15
DELISTED
Desktop Metal, Inc.
DM
| $33.1M | 2.29% | 14,398,927 | – | – |
|
|
OKUR
16
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $28.6M | 1.98% | 4,785,494 | – | – |
|
|
ALLK
17
DELISTED
Allakos
ALLK
| $27.4M | 1.89% | 6,147,260 | – | – |
|
|
ZFOX
18
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $26.4M | 1.82% | 18,068,513 | – | – |
|
19
CVRx
CVRX
$205M
| $22.1M | 1.53% | 2,370,542 | – | – |
|
20
Trevi Therapeutics
TRVI
$883M
| $21M | 1.45% | 11,370,376 -2,798 | -0% | -$5.18K |
|
|
ADAP
21
Adaptimmune Therapeutics
ADAP
$15.6M
| $18.6M | 1.29% | 17,079,779 | – | – |
|
22
BuzzFeed
BZFD
$72.6M
| $17.3M | 1.2% | 15,333,892 | – | – |
|
23
NextNav
NN
$2.37B
| $16.6M | 1.15% | 8,189,156 | – | – |
|
|
CTIC
24
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $15.5M | 1.07% | 3,685,683 | – | – |
|
|
INZY
25
DELISTED
Inozyme Pharma
INZY
| $14M | 0.97% | 2,437,689 | – | – |
|